It’s more than two decades since targeted protein degradation (TPD) and induced proximity was identified as a new modality. Since then, it’s clear that TPD can potentially address proteins that are otherwise challenging to target with traditional small molecules. 

Over a number of years, Charnwood Discovery has invested in and developed expertise in designing, making and understanding targeted protein degraders, with a focus on PROTACs and molecular glues. On the right we list just some of our TPD resources exemplifying our work, including our latest innovation in ‘Measuring PROTAC Ternary Complex Formation by SPR’. 

Our expert multi-disciplinary teams can help you build and develop a robust TPD drug discovery pipeline. Contact us to discuss your requirements.